CCR5 antagonists (Millennium)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCCR5 antagonists (Millennium)
Drug Alias NameCCR5 antibody (LeukoSite)anti-CCR5 monoclonal antibody (Millennium)CCR5 antagonists (LeukoSite)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsRejection of organ transplantationHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeukosite
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeukositeMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A